GP2 and neoplasm: VNPs displaying gpD (λ) fused to GP2, a peptide derivative from the overexpressed tumor protein HER2/nue, generated a strong cytotoxic T lymphocyte response that had anti-tumor activity when given prophylactically or therapeutically in a mouse model [138].